Menu
Sign up
Login
Menu
Sign up
Login
The life science and pharma industry is in a transformative phase where targets formerly considered un-druggable are now the focus of well-funded biotech companies.... → read more
September 29-25, 2024
How to translate your oncology target into a preclinical candidate (PART 2)... → read more
September 16-25, 2024
Join live Dr. Martin Lange and Dr. Carlo Stresemann on a short journey into the oncology and translational research services at NUVISAN-ICB.... → read more
June 17-25, 2024
Administration of large molecules can trigger an immune response in patients, leading to the production of anti-drug-antibodies (ADA).... → read more
April 20-25, 2024
High throughput Screening (HTS) is a key element of the early drug discovery process and essential for the identification of molecules with suitable target-specific properties to develop a promising drug.... → read more
March 30-25, 2024
Biomarkers are measurable characteristics of a living organism, from blood pressure to the abundance of proteins or small molecule metabolites.... → read more
February 11-25, 2024
The pharmaceutical industry is often seen as an expensive activity that requires considerable R&D investments with no guaranties of return.... → read more
December 3-25, 2024
Most topical formulations developed today are complex and require tight control to be chemically and physically stable while meeting the targeted efficiency and delivering pleasant aesthetics.... → read more
October 20-25, 2024
The increasing complexity in the early development phase led to a booming demand for sophisticated CRO/CDMO partners.... → read more
July 28-25, 2024
lorem ipsum dolor sit amet... → read more
November 20, 2021
... → read more
November 20, 2021
Curious about the discovery and development of next generation drugs?... → read more
December 21-22, 2023
The NUVISAN team is happy to support you.
For sales enquiries, please schedule a meeting HERE or email us at hello@nuvisan.com.
For technical issues, please email us at marketing@nuvisan.com or call +49 731 9840 111.
